Cytokinetics (NASDAQ:CYTK) is set to give its latest quarterly earnings report on Tuesday, 2026-02-24. Here's what investors need to know before the announcement.

Analysts estimate that Cytokinetics will report an earnings per share (EPS) of $-1.41.

The announcement from Cytokinetics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Performance in Previous Earnings

The company's EPS beat by $0.04 in the last quarter, leading to a 1.88% increase in the share price on the following day.

Here's a look at Cytokinetics's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-1.58	-1.35	-1.36	-1.17
EPS Actual	-1.54	-1.12	-1.36	-1.26
Price Change %	2.00	-3.00	-3.00	-3.00

Tracking Cytokinetics's Stock Performance

Shares of Cytokinetics were trading at $67.94 as of February 20. Over the last 52-week period, shares are up 46.92%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Cytokinetics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.